{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-24-008140","form_type":"8-K","ticker":"PMN","cik":"0001374339","company_name":"ProMIS Neurosciences Inc.","filed_at":"2024-05-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.140970+00:00","generated_at":"2026-06-02T00:32:08.836198+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"ProMIS Neurosciences Q1 net loss $3.6M; cash $2.5M; Phase 1a data on track for mid-2024","bullets":["Cash and equivalents $2.5M at March 31, 2024, down from $12.6M at Dec 31, 2023.","Net loss $3.6M in Q1 2024 versus $5.0M in Q1 2023; R&D $2.1M, G&A $1.6M.","Phase 1a PMN310 top-line data expected mid-2024; Phase 1b planned H2 2024 subject to resources.","Neil Warma appointed interim CEO in January 2024, continues as CEO and director."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-24-008140","json":"https://secwatch.observer/filing/0001558370-24-008140.json","markdown":"https://secwatch.observer/filing/0001558370-24-008140.md","text":"https://secwatch.observer/filing/0001558370-24-008140.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1374339/000155837024008140/0001558370-24-008140-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1374339/000155837024008140/pmn-20240514x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T00:32:08.836198+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c68b72ed758f38abb067e94eb36e95f72d6def50","claim":"ProMIS Neurosciences Inc. reported the first quarter ended March 31, 2024 results: net income Net loss was $3.6 million for the quarter ended March 31, 2024.","evidence_excerpt":"Net loss was $3.6 million for the quarter ended March 31, 2024, compared to a net loss of $5.0 million for the same period in 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1374339/000155837024008140/0001558370-24-008140-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter ended March 31, 2024"},{"label":"Net income","value":"Net loss was $3.6 million for the quarter ended March 31, 2024"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}